In this review, we take a step back and map where CRISPR-based therapeutics stand today across the globe: the tools, the clinical progress, the challenges and where the field is heading next. It’s been humbling to pull this landscape together with such a large and brilliant group of collaborators.
https://hdl.handle.net/10045/169163
